← Back to Search

Endovascular Graft

Endovascular Graft for Abdominal Aortic Aneurysm (FENP Trial)

N/A
Waitlist Available
Led By James F. McKinsey, MD
Research Sponsored by Cook Research Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Penetrating juxtarenal aortic ulcer > 10 mm in depth and 20 mm in diameter
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

FENP Trial Summary

This trial is studying the safety and effectiveness of two types of endovascular grafts for the treatment of abdominal aortic aneurysms.

Eligible Conditions
  • Abdominal Aortic Aneurysm

FENP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have a large, deep ulcer in a specific part of your aorta.

FENP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
evaluate perfusion of visceral vessels

FENP Trial Design

1Treatment groups
Experimental Treatment
Group I: EndovascularExperimental Treatment1 Intervention
Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft
2008
N/A
~30

Find a Location

Who is running the clinical trial?

Cook Research IncorporatedLead Sponsor
29 Previous Clinical Trials
253,842 Total Patients Enrolled
James F. McKinsey, MDPrincipal InvestigatorMount Sinai-West

Media Library

Zenith® Fenestrated AAA Endovascular Graft (Endovascular Graft) Clinical Trial Eligibility Overview. Trial Name: NCT01652235 — N/A
Abdominal Aortic Aneurysm Research Study Groups: Endovascular
Abdominal Aortic Aneurysm Clinical Trial 2023: Zenith® Fenestrated AAA Endovascular Graft Highlights & Side Effects. Trial Name: NCT01652235 — N/A
Zenith® Fenestrated AAA Endovascular Graft (Endovascular Graft) 2023 Treatment Timeline for Medical Study. Trial Name: NCT01652235 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this investigation still available to participants?

"The clinicaltrials.gov database has marked this medical trial as not actively recruiting at present, having been first posted on July 1st 2008 and most recently updated December 15th 2021. However, 153 other trials are presently enrolling patients into their programs."

Answered by AI
~2 spots leftby Mar 2025